当前位置:首页 - 行情中心 - 索宝蛋白(603231) - 财务分析 - 现金流量表

索宝蛋白

(603231)

  

流通市值:21.42亿  总市值:38.60亿
流通股本:1.06亿   总股本:1.91亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金774,628,905.1401,336,324.321,689,917,285.061,232,983,351.19
  收到的税费返还34,268,039.7914,509,292.9564,053,774.3653,069,243.32
  收到其他与经营活动有关的现金9,614,465.748,325,603.3439,305,706.3133,939,425.1
  经营活动现金流入小计818,511,410.63424,171,220.611,793,276,765.731,319,992,019.61
  购买商品、接受劳务支付的现金676,267,894.88409,894,840.831,456,789,183.71,040,062,645.91
  支付给职工以及为职工支付的现金62,303,117.6537,015,666.27103,715,232.1973,058,658.81
  支付的各项税费27,343,901.1313,977,278.6936,712,493.134,793,671.95
  支付其他与经营活动有关的现金23,787,757.3119,167,854.7648,374,337.6753,953,937.19
  经营活动现金流出小计789,702,670.97480,055,640.551,645,591,246.661,201,868,913.86
  经营活动产生的现金流量净额28,808,739.66-55,884,419.94147,685,519.07118,123,105.75
二、投资活动产生的现金流量:
  取得投资收益收到的现金4,139,015.566,930,144.1210,816,629.527,402,840.59
  处置固定资产、无形资产和其他长期资产收回的现金净额187,011.78-411,935.59248,400
  收到的其他与投资活动有关的现金1,274,380,000783,180,0001,508,710,000792,010,000
  投资活动现金流入小计1,278,706,027.34790,110,144.121,519,938,565.11799,661,240.59
  购建固定资产、无形资产和其他长期资产支付的现金54,962,134.1737,813,968.06168,511,204.9656,426,483.95
  支付其他与投资活动有关的现金1,260,909,444.44893,709,444.442,007,390,0001,503,890,285.39
  投资活动现金流出小计1,315,871,578.61931,523,412.52,175,901,204.961,560,316,769.34
  投资活动产生的现金流量净额-37,165,551.27-141,413,268.38-655,962,639.85-760,655,528.75
三、筹资活动产生的现金流量:
  取得借款收到的现金23,774,00023,774,00023,774,00023,774,000
  筹资活动现金流入小计23,774,00023,774,00023,774,00023,774,000
  偿还债务支付的现金23,774,00023,774,00083,774,00083,774,000
  分配股利、利润或偿付利息支付的现金57,498,564.98120,489.6895,904,677.9996,470,370.36
  支付其他与筹资活动有关的现金1,052,821.03-93,568,972.4792,674,495.76
  筹资活动现金流出小计82,325,386.0123,894,489.68273,247,650.46272,918,866.12
  筹资活动产生的现金流量净额-58,551,386.01-120,489.68-249,473,650.46-249,144,866.12
四、汇率变动对现金及现金等价物的影响7,497,128.961,740,972.574,628,003.852,541,831.44
五、现金及现金等价物净增加额-59,411,068.66-195,677,205.43-753,122,767.39-889,135,457.68
  加:期初现金及现金等价物余额320,021,347.41320,021,347.411,073,144,114.81,073,144,114.8
  期末现金及现金等价物余额260,610,278.75124,344,141.98320,021,347.41184,008,657.12
补充资料:
  净利润97,432,394.07-121,180,733.75-
  资产减值准备-16,626.41-4,052,226.63-
  固定资产和投资性房地产折旧32,652,700.05-65,223,992.96-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧32,652,700.05-65,223,992.96-
  无形资产摊销1,031,264.7-3,361,921.41-
  处置固定资产、无形资产和其他长期资产的损失499,658.78-29,666.68-
  固定资产报废损失224,051.15-2,862,170.51-
  公允价值变动损失-2,926,444.79--6,201,917.5-
  财务费用77,609.38-140,609.19-
  投资损失-702,493.6--5,341,043.26-
  递延所得税-326,878.29--1,157,960.85-
  其中:递延所得税资产减少19,337.71-123,395.36-
    递延所得税负债增加-346,216--1,281,356.21-
  存货的减少-6,473,890.82--68,312,954.74-
  经营性应收项目的减少-18,782,796.71-10,112,997.07-
  经营性应付项目的增加-67,320,046.24-29,676,150.13-
  其他-7,497,128.96--4,622,822.26-
  现金的期末余额260,610,278.75-320,021,347.41-
  减:现金的期初余额320,021,347.41-1,073,144,114.8-
  现金及现金等价物的净增加额-59,411,068.66--753,122,767.39-
公告日期2025-08-282025-04-252025-04-252024-10-26
审计意见(境内)标准无保留意见
TOP↑